Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. (Q54302479)

27 May 2018

title

Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. (English)

1 reference

27 May 2018

1 reference

Heidenreich S

1

1 reference

27 May 2018

Rahn KH

series ordinal

2

1 reference

27 May 2018

Zidek W

series ordinal

3

1 reference

27 May 2018

language of work or name

English

0 references

publication date

1 February 1991

1 reference

27 May 2018

published in

Kidney International

1 reference

27 May 2018

volume

39

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

259-265

1 reference

27 May 2018

The kidney and erythropoiesis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Isolation and characterization of genomic and cDNA clones of human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Cloning and expression of the human erythropoietin gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Hemodynamics of uremic anemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Recombinant erythropoietin and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

The active tension-length curve of vascular smooth muscle related to its cellular components

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Erythropoietin and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.31

7 January 2021

Identifiers

DOI

10.1038/KI.1991.31

1 reference

27 May 2018

1 reference

27 May 2018